Barclays raised the firm’s price target on HCA Healthcare to $376 from $367 and keeps an Overweight rating on the shares as part of a Q2 earnings preview for the managed care space.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on HCA:
- HCA Healthcare price target raised to $375 from $359 at Deutsche Bank
- Augmedix says Go ED has met HCA’s criteria for expansion
- HCA business thriving, hospitals paying a price, Barron’s says
- HCA Healthcare price target raised to $332 from $327 at JPMorgan
- HCA Healthcare initiated with an Outperform at Baird